ID: MRFR/MED/0121-HCR | February 2021 | Region: Global | 80 pages
Insulin is a hormone produced by the pancreas. A diabetes pen is used to inject insulin for the treatment of diabetes. It is composed of an insulin cartridge (integrated or bought separately) and a dial to measure the dose, and is used with disposable pen needles to deliver the dose. Diabetes is a major chronic disease across the globe. Changing lifestyle, high intake of carbohydrates and sugar, and obesity are major factors elevating the prevalence of the disease. Increasing prevalence of diabetes and obesity and growing demand for diabetes pen drive the market for diabetes pen.
The global diabetes pen market is expected to grow at a CAGR of approximately 8.45% during the forecast period 2017-2023.
Figure 1: Global Diabetes Pen Market by Region, 2016 (%)
The global diabetes pen market is segmented on the basis of product, which includes insulin pens and insulin pen needles. On the basis of usage, the market is segmented into reusable pens and disposable pens. On the basis of distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, online sales, and diabetes clinics.
Key Players for Diabetes Pen Market
Some of the key players in this market: AstraZeneca (U.K), Teruma Medical Corporation (Japan), Greinier Bio One International GmBH (U.S.), F. Hoffman La Roche AG (Switzerland), Becton, Dickinson and Company (U.S.), Bayer Cropscience Ltd. (Germany), and HTL STREFA SA (Poland)
Figure 2: Market Synopsis
Regional Analysis of Diabetes Pen Market
The global diabetes pen market consists of four regions: Americas, Europe, Asia Pacific and The Middle East & Africa. North America is the largest market for diabetes pen due to large diabetic population and better awareness and reimbursement policy for diabetes management. Additionally, continuous technological advancements in diabetes pen and increasing research and development practices drive this market in North America.
Europe is the second-largest market for diabetes pen which is expected to grow at a CAGR of 1.05% from 2017 to 2023. Extensive use of diabetes pen is been found is UK is compared to other European nations. According to the World Health Organization, nearly 60 million people with diabetes in the European Region and the prevalence is higher among people aging 25 years and above.
Asia Pacific is expected to be the fastest growing market for diabetes pen over the review period. Evolving healthcare infrastructure, improving awareness, large patient pool, and growing healthcare expenditure drive the Asia Pacific diabetes pen market. Furthermore, new product launch and favorable regulations speed up the growth of this market in Asia Pacific. India, Japan and China is expected to be the emerging and fastest growing market. India is known as the hub of diabetes across the world. India is experiencing growing demand for diabetes pens due to rising geriatric population with diabetes and irregular changes in sugar levels. Majority of people face the problem of obesity and other lifestyle diseases, which act as risk factors for diabete, which boost the demand for diabetes pen.
In Middle East & Africa will witness steady growth due to growing awareness regarding lifestyle diseases and preventive measures to tackle elevated sugar levels Africa.
Frequently Asked Questions (FAQ) :
The 8.45% CAGR would be the forecast period (2017-2023).
The players are Teruma Medical Corporation (Japan), AstraZeneca (U.K), F. Hoffman La Roche AG (Switzerland), Greinier Bio One International GmBH (U.S.), Bayer Cropscience Ltd. (Germany), Becton, Dickinson, and Company (U.S.), and HTL STREFA SA (Poland).
The distribution channels are online sales, retail pharmacy, hospital pharmacy, and diabetes clinics.
North America is leading the market with maximum market share.
The Asia Pacific is showing signs of growth with the fastest speed.
1. Report Prologue
2.2 Scope of the Study
2.2.1 Research Objective
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4. Market Dynamics
4.4 Mega Trends
4.5 Macroeconomic Indicators
5. Market Factor Analysis
5.1 Value Chain Analysis
5.2 Porters Five Forces
5.3 demand & supply: gap analysis
5.4 Pricing Analysis
5.5 Investment Opportunity Analysis
5.6 Merger and Acquisition Landscape
5.7 UP-Coming trends in Diabetes Pen market
5.7.1 Market trends
5.7.2 Technological trends
6. Europe Diabetes Pen Market by Product
6.2 Insulin Pens
6.3 Insulin Pen Needle
7. Europe Diabetes Pen Market by Usage
7.2 Reusable Pens
7.3 Disposable Pens
8. Europe Diabetes Pen Market by Distribution Channel
8.2 Hospital Pharmacy
8.3 Retail Pharmacy
8.4 Online Sales
8.5 Diabetes Clinics
9. Europe Diabetes Pen Market by Region
9.2.1 North America
9.2.2 South America
9.3.1 Western Europe
188.8.131.52 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.4 Republic of Korea
9.4.6 Rest of Asia Pacific
9.5 Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.6 Rest of Middle East & Africa
10 Competitive Landscape
11 Company Profile
11.1 Teruma Medical Corporation
11.1.2 Product/Business Segment Overview
11.1.3 Financial Updates
11.1.4 Key Developments
11.2 Greinier Bio One International GmBH
11.2.2 Product/Business Segment Overview
11.2.3 Financial Updates
11.2.4 Key Developments
11.3 F. Hoffman La Roche AG
11.3.2 Product/Business Segment Overview
11.3.3 Financial Updates
11.3.4 Key Developments
11.4 Becton, Dickinson and Company
11.4.2 Product/Business Segment Overview
11.4.3 Financial Updates
11.4.4 Key Developments
11.5 Bayer Cropscience Ltd.
11.5.2 Product/Business Segment Overview
11.5.3 Financial Updates
11.5.4 Key Developments
11.6 HTL STREFA SA
11.6.2 Product/Business Segment Overview
11.6.3 Financial Updates
11.6.4 Key Developments
11.7.2 Product/Business Segment Overview
11.7.3 Financial Updates
11.7.4 Key Developments
12.1 Key Findings
12.1.1 From CEO`s Viewpoint
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Prediction of Medical Device Industry